Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 161

1.

Adalimumab Dose-Escalation Therapy Is Effective in Refractory Crohn's Disease Patients with Loss of Response to Adalimumab, Especially in Cases without Previous Infliximab Treatment.

Suzuki T, Mizoshita T, Sugiyama T, Hirata Y, Kimura Y, Suzuki Y, Yamada T, Tsukamoto H, Mizushima T, Sugimura N, Katano T, Tanida S, Kataoka H, Sasaki M.

Case Rep Gastroenterol. 2019 Feb 6;13(1):37-49. doi: 10.1159/000496453. eCollection 2019 Jan-Apr.

2.

Successful peroral endoscopic removal of migrated metal stent.

Hori Y, Hayashi K, Sobajima Y, Naitoh I, Miyabe K, Yoshida M, Kataoka H.

Endoscopy. 2019 Jun 4. doi: 10.1055/a-0915-1756. [Epub ahead of print] No abstract available.

PMID:
31163485
3.

A Basic Study of Photodynamic Therapy with Glucose-Conjugated Chlorin e6 Using Mammary Carcinoma Xenografts.

Osaki T, Hibino S, Yokoe I, Yamaguchi H, Nomoto A, Yano S, Mikata Y, Tanaka M, Kataoka H, Okamoto Y.

Cancers (Basel). 2019 May 8;11(5). pii: E636. doi: 10.3390/cancers11050636.

4.

Endoscopic drainage using a lumen-apposing metal stent under contrast-enhanced harmonic endoscopic ultrasonography guidance.

Hori Y, Yoshida M, Hayashi K, Naitoh I, Kato A, Miyabe K, Kataoka H.

Endoscopy. 2019 Apr 12. doi: 10.1055/a-0875-3546. [Epub ahead of print] No abstract available.

PMID:
30978734
5.

Placental growth factor is a predictive biomarker for ramucirumab treatment in advanced gastric cancer.

Natsume M, Shimura T, Iwasaki H, Okuda Y, Kitagawa M, Okamoto Y, Hayashi K, Kataoka H.

Cancer Chemother Pharmacol. 2019 Jun;83(6):1037-1046. doi: 10.1007/s00280-019-03817-2. Epub 2019 Mar 21.

PMID:
30899983
6.

Real-world efficacy of adalimumab and infliximab for refractory intestinal Beh├žet's disease.

Sugimura N, Mizoshita T, Sugiyama T, Togawa S, Miyaki T, Suzuki T, Tanida S, Kataoka H, Sasaki M.

Dig Liver Dis. 2019 Jul;51(7):967-971. doi: 10.1016/j.dld.2018.10.024. Epub 2019 Feb 19.

PMID:
30872086
7.

Intestinal obstruction caused by small bowel adenocarcinoma misdiagnosed as psychogenic disorder.

Nishie H, Suzuki T, Ichikawa H, Kataoka H.

BMJ Case Rep. 2019 Jan 28;12(1). pii: bcr-2018-227326. doi: 10.1136/bcr-2018-227326.

PMID:
30696643
8.

Urinary Cysteine-Rich Protein 61 and Trefoil Factor 3 as Diagnostic Biomarkers for Colorectal Cancer.

Shimura T, Iwasaki H, Kitagawa M, Ebi M, Yamada T, Yamada T, Katano T, Nisie H, Okamoto Y, Ozeki K, Mizoshita T, Kataoka H.

Transl Oncol. 2019 Mar;12(3):539-544. doi: 10.1016/j.tranon.2018.12.006. Epub 2019 Jan 3.

9.

Proton-pump inhibitor-induced fundic gland polyps with hematemesis.

Tanaka M, Kataoka H, Yagi T.

Clin J Gastroenterol. 2019 Apr;12(2):193-195. doi: 10.1007/s12328-018-0908-7. Epub 2018 Sep 24.

PMID:
30251013
10.

An Increased Chromosome 7 Copy Number in Endoscopic Bile Duct Biopsy Specimens Is Predictive of a Poor Prognosis in Cholangiocarcinoma.

Kato A, Naitoh I, Miyabe K, Hayashi K, Yoshida M, Hori Y, Natsume M, Jinno N, Asano G, Kato H, Kuno T, Takahashi S, Kataoka H.

Dig Dis Sci. 2018 Dec;63(12):3376-3381. doi: 10.1007/s10620-018-5280-4. Epub 2018 Sep 12.

PMID:
30206756
11.

Colorectal obstruction is a potential prognostic factor for stage II colorectal cancer.

Okuda Y, Shimura T, Yamada T, Hirata Y, Yamaguchi R, Sakamoto E, Kataoka H.

Int J Clin Oncol. 2018 Dec;23(6):1101-1111. doi: 10.1007/s10147-018-1307-2. Epub 2018 Jun 15.

PMID:
29948240
12.

Utility of a Fluorescence Microscopy Imaging System for Analyzing the DNA Ploidy of Pathological Megakaryocytes Including 5q- Syndrome.

Nakahara T, Suemori S, Tsujioka T, Kataoka M, Kataoka H, Shibakura M, Tohyama K.

Acta Med Okayama. 2018 Jun;72(3):249-256. doi: 10.18926/AMO/56070.

13.

Long-term Outcomes of One Stage Surgery Using Transanal Colorectal Tube for Acute Colorectal Obstruction of Stage II/III Distal Colon Cancer.

Okuda Y, Yamada T, Hirata Y, Shimura T, Yamaguchi R, Sakamoto E, Sobue S, Nakazawa T, Kataoka H, Joh T.

Cancer Res Treat. 2019 Apr;51(2):474-482. doi: 10.4143/crt.2018.059. Epub 2018 Jun 6.

14.

Combination Therapy With Intensive Granulocyte and Monocyte Adsorptive Apheresis Plus Ustekinumab in Patients With Refractory Crohn's Disease.

Tanida S, Mizoshita T, Ozeki K, Katano T, Tanaka M, Nishie H, Shimura T, Okamoto Y, Kubota E, Kataoka H, Joh T.

Ther Apher Dial. 2018 Jun;22(3):295-300. doi: 10.1111/1744-9987.12697. Epub 2018 May 23.

PMID:
29790276
15.

The Successful Treatment of Metastatic Extraosseous Ewing Sarcoma with Pazopanib.

Mori Y, Kinoshita S, Kanamori T, Kataoka H, Joh T, Iida S, Takemoto M, Kondo M, Kuroda J, Komatsu H.

Intern Med. 2018 Sep 15;57(18):2753-2757. doi: 10.2169/internalmedicine.9879-17. Epub 2018 May 18.

16.

Glucagon promotes colon cancer cell growth via regulating AMPK and MAPK pathways.

Yagi T, Kubota E, Koyama H, Tanaka T, Kataoka H, Imaeda K, Joh T.

Oncotarget. 2018 Jan 31;9(12):10650-10664. doi: 10.18632/oncotarget.24367. eCollection 2018 Feb 13.

17.

Refractory gastric antral ulcers without Helicobacter pylori infection and non-steroidal anti-inflammatory drugs.

Nishie H, Kataoka H, Kato H, Suzuki T, Ichikawa H, Nojiri Y, Kitagawa M, Inagaki Y, Iwasaki H, Tanaka M, Katano T, Okamoto Y, Ozeki K, Mizoshita T, Shimura T, Kubota E, Tanida S, Joh T.

Clin J Gastroenterol. 2018 Jun;11(3):251-256. doi: 10.1007/s12328-018-0835-7. Epub 2018 Feb 16.

PMID:
29453508
18.

Excellent antitumor effects for gastrointestinal cancers using photodynamic therapy with a novel glucose conjugated chlorin e6.

Nishie H, Kataoka H, Yano S, Yamaguchi H, Nomoto A, Tanaka M, Kato A, Shimura T, Mizoshita T, Kubota E, Tanida S, Joh T.

Biochem Biophys Res Commun. 2018 Feb 19;496(4):1204-1209. doi: 10.1016/j.bbrc.2018.01.171. Epub 2018 Jan 31.

PMID:
29408755
19.

Anti-tumor efficacy of oncolytic reovirus against gastrointestinal stromal tumor cells.

Inagaki Y, Kubota E, Mori Y, Aoyama M, Kataoka H, Johnston RN, Joh T.

Oncotarget. 2017 Dec 18;8(70):115632-115646. doi: 10.18632/oncotarget.23361. eCollection 2017 Dec 29.

20.

Evaluation of the accuracy of estimated baseline serum creatinine for acute kidney injury diagnosis.

Hatakeyama Y, Horino T, Nagata K, Kataoka H, Matsumoto T, Terada Y, Okuhara Y.

Clin Exp Nephrol. 2018 Apr;22(2):405-412. doi: 10.1007/s10157-017-1481-y. Epub 2017 Oct 5.

PMID:
28983757

Supplemental Content

Loading ...
Support Center